Cocrystal Pharma, Inc.
COCP
$1.31
$0.010.77%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.83M | -9.67M | -12.56M | -15.85M | -17.50M |
| Total Depreciation and Amortization | 72.00K | 87.00K | 75.00K | 103.00K | 126.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 273.00K | 307.00K | 539.00K | 636.00K | 753.00K |
| Change in Net Operating Assets | 294.00K | -339.00K | -1.43M | 189.00K | 140.00K |
| Cash from Operations | -8.19M | -9.62M | -13.38M | -14.92M | -16.49M |
| Capital Expenditure | -12.00K | -12.00K | 0.00 | 0.00 | -8.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -12.00K | -12.00K | 0.00 | 0.00 | -8.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.37M | 4.34M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.37M | 4.34M | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.84M | -5.29M | -13.38M | -14.92M | -16.49M |